Emicizumab Use in Pediatric Patients in the Real World: an Analysis of the PedNet Registry

27/11/2019
01/10/2025
EU PAS number:
EUPAS31954
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Prot MO40685 (PEDNET) emicizumab v1_Redacted

English (593.4 KB - PDF) View document
Updated protocol

MO40685 (PEDNET)-Protocol v2_Redacted

First published: 22/02/2024
English (284.5 KB - PDF) View document
Study results
Study report
Study report

Interim_CSR,_Study_MO40685_(PEDNET),_PASS_Annual_Report_30Sep2020,_Published_Output-1_Redacted

English (905.63 KB - PDF) View document

MO40685 (PEDNET)-Interim CSR Synopsis 2, PASS Annual Report_30Sep2021_Redacted

English (1.43 MB - PDF) View document

MO40685 (PEDNET)-Interim CSR Synopsis 3_PASS Annual Report_28Sep2022_Redacted

English (601.02 KB - PDF) View document

MO40685 (PEDNET)-Interim CSR Synopsis 4_Annual Report_29-Sep-2023_Redacted.pdf

English (629.55 KB - PDF) View document

MO40685 (PEDNET)-Interim CSR Synopsis 5_Annual Report_17-Sep-2024_Redacted.pdf

English (492.51 KB - PDF) View document

MO40685 (PEDNET)-Final CSR Synopsis_Redacted.pdf

English (586.69 KB - PDF) View document
Other information